CYNTHIA KEPFER: Open Payments
NPI 1770029597 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 34 payments from 7 companies in 2025. Trend: 2023 $371 · 2024 $304 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $186 |
| Teva Pharmaceuticals USA, Inc. | 7 | $135 |
| Alkermes, Inc. | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: VRAYLAR, ARISTADA, UZEDY, AUSTEDO XR, COBENFY, ABILIFY ASIMTUFII, INGREZZA, CAPLYTA.
Industry payments across FL — which companies pay providers there.
